Viewing Study NCT05563961


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2025-12-27 @ 9:34 PM
Study NCT ID: NCT05563961
Status: RECRUITING
Last Update Posted: 2024-03-27
First Post: 2022-09-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
Sponsor: Sinew Pharma Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Oral AAP-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators